Ischemia Care is a rapidly growing diagnostics company based in Middletown, OH, specializing in the development and commercialization of a breakthrough stroke blood testing platform. Their innovative technology provides highly accurate diagnosis guidance to clinicians, enabling rapid treatment of complex and chronic stroke patients.
Ischemia Care is the world's only company with clinical experience using RNA expression to understand stroke at a molecular level, delivering personalized patient care. Their state-of-the-art CLIA laboratory provides information leading to clinical evidence-based care, and their testing has completed the rigorous CLIA analytical validation process overseen by the FDA, CMS, and CDC. With a focus on cost-effective stroke care, Ischemia Care aims to improve patient outcomes and reduce hospital costs through their innovative diagnostic solutions.
Generated from the website